Pharma's Prescription bridges the knowledge gap between current business practices and the most valuable technologies today. This book is filled with practical, real-life examples from industry and is a straightforward guide for all pharmaceutical and information technology executives who need to improve their businesses.
- Focuses on practical solutions that are easily incorporated in your day-to-day work- Integrates business operations and information technology- Highlights the industry's top turn-around stories- Discusses pharmaceutical industry trends, growth opportunities, innovation drivers, regulatory complexities, and emerging market operations
Chapter 1: Pharma Health-Critical Parts Need Redesigning Chapter 2: The Pharmaceutical Value Chain-An Introduction Chapter 3: Technology Basics-An Introduction Chapter 4: Courageous New World: Strategies to Improve Business Outcomes Chapter 5: Measuring Business Values and Success
Kamal Biswas is a Partner and Leader of the Global Life Sciences Consulting Practice at Infosys. He has nearly two decades of hands-on experience in the pharmaceutical industry. Kamal worked for 10 years in pharmaceutical technical R&D, manufacturing plant design, manufacturing operations and new product launches. Kamal moved into management consulting to drive forward industry growth and margin preservation, accelerate innovation and improve compliance. He has worked with many pharmaceutical majors including Ciba Geigy, Novartis, Pfizer, GSK, Aventis, J&J and BMS, either as an employee or as a consultant.
Kamal has also developed several technology driven solutions that have helped pharmaceutical companies transform business functions to enhance business values for the company and customers. He has worked in Europe, Asia and the Americas and currently lives with his family in the US. He has a Masters in Engineering, went to business school for International Marketing, is a certified ISO9000 Quality Auditor, and member of the board in several industry forums. Kamal is a strategist and evangelist of pharmaceutical business transformation through non-traditional methods and frequently speaks at industry councils.